The suit was filed Dec. 2 on behalf of children allegedly sickened by the hospital mold, according to KIRO 7, and claims Seattle Children’s “engaged in years of cover-up designed to reassure its patients, doctors, nurses and the public that its premises were safe, when in fact they were not.”
Katha and Micah Hutt have joined the class-action suit, saying their daughter, Elizabeth Hutt, contracted Aspergillus during one or both of her surgeries in August or November 2019 at Seattle Children’s. The surgeries occurred in between operating room shutdowns due to mold outbreaks at the facility.
The Washington State Department of Health completed an on-site investigation at the hospital, it announced in a Jan. 8 statement. The investigation found Seattle Children’s in compliance with all regulations regarding governance, physical environment, infection control and quality assurance. However, the department verified the presence of mold, stating that “serious mitigation efforts” are currently underway to address the issue.
More articles on clinical leadership and infection control:
US cancer death rates see largest single-year drop on record
Most Americans believe MMR vaccine does its job well, survey says
1st flu deaths reported in Delaware
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
